Collplant Biotechnologies LTD (CLGN) SEC Filings — 2025

Filings

• CollPlant Biotechnologies Files December 2025 6-K Report — 6-K · Dec 31, 2025
• CollPlant Biotechnologies Files November 2025 6-K Report — 6-K · Nov 26, 2025
• CollPlant Expands rhCollagen Distribution Network — 6-K · Oct 27, 2025
• CollPlant's Vergenz Bio-Ink Shows High Success in Diabetic Foot Ulcer Trial — 6-K · Oct 20, 2025
• CollPlant Unveils Novel 3D Bioprinted Osteoarthritis Treatment — 6-K · Oct 16, 2025
• CollPlant Biotechnologies Files 6-K Report — 6-K · Sep 30, 2025
• CollPlant Expands Vergenix Distribution — 6-K · Sep 15, 2025
• CollPlant Seeks Nasdaq Upgrade — 6-K · Sep 12, 2025
• CollPlant Biotechnologies Files 6-K Report — 6-K · Aug 20, 2025
• CollPlant Appoints Collagen Biomaterials Expert as CSO — 6-K · Jul 14, 2025
• CollPlant Expands STEMCELL Collaboration — 6-K · Jun 9, 2025
• CollPlant Biotechnologies Secures European Patent for BioInk — 6-K · Jun 4, 2025
• CollPlant Biotechnologies Files June 2025 6-K Report — 6-K · Jun 2, 2025
• CollPlant Biotechnologies Files May 2025 6-K Report — 6-K · May 30, 2025
• CollPlant Biotechnologies Reports Q1 2025 Financials — 6-K · May 28, 2025
• CollPlant Bio's Collink.3D® Shows High Success in Bone Regeneration Study — 6-K · Apr 15, 2025
• CollPlant Biotechnologies Files 2024 Annual Report — 20-F · Mar 26, 2025
• CollPlant Biotechnologies Files Form 6-K for February 2025 — 6-K · Feb 24, 2025
• CollPlant Gets New Patent for Dermal Filler — 6-K · Feb 12, 2025